Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qifu Yixin Prescription
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Qifu Yixin Prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital, which is affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily being investigated as an adjunctive therapy for patients with heart failure with preserved ejection fraction (HFpEF). The prescription is typically administered in a granule dosage form and is intended to be used alongside standard Western medical treatments. Clinical evaluation focuses on its ability to improve cardiac function, enhance exercise tolerance, and improve the quality of life for patients, while also addressing specific TCM syndrome scores. The formula's name suggests the inclusion of *Astragalus membranaceus* (Huangqi) and *Aconitum carmichaelii* (Fuzi), which are traditionally used in TCM to support heart function and circulation.
- Other names
- Qifu Yixin FormulaQifu Yixin GranulesQi Fu Yi Xin Fang
02
Targets
SUMO1 (Small ubiquitin-like modifier 1)SERCA2sGC (Soluble Guanylyl Cyclase)ARRB2 (Beta-arrestin-2)
Beyond the preview
Go deeper on Qifu Yixin Prescription.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qifu Yixin Prescription.